Emergencies, Cervical Cancer, IP & Innovation Among Highlights Of Member State Consultations Ahead Of WHO Executive Board 09/01/2020 Editorial team Ahead of the upcoming WHO Executive Board meeting 3-8 February, WHO has launched a series of informal consultations this week with member state representatives on key issues that will be coming before the governing body – and ultimately the May meeting of the World Health Assembly (WHA). The detailed consultation agenda, published on the WHO […] Continue reading -> Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> Leveraging Urban Leaders To Battle NCDs – Healthy Cities Partnership Expands To 70 12/12/2019 Elaine Ruth Fletcher From clearing the air of hookah smoke in Amman, Jordan to bike lanes in Fortaleza, Brazil and salt-free menu options in the restaurants of Montevideo, Uruguay, the Partnership for Healthy Cities has been seeding small grants to cities across the globe – backed by a big ambition. The aim is to build a network of […] Continue reading -> Beat NCDs With Healthier Behaviours, Environments & Education, Says WHO High-Level Commission 10/12/2019 Elaine Ruth Fletcher Make the ¨healthiest choices the easiest choices¨ to prevent many non-communicable diseases. This was a key message from an Independent High-Level Commission report on Non-communicable diseases (NCDs), released Tuesday at a WHO Global Meeting to Accelerate Progress NCDs and Mental Health in Muscat, Oman. The report, ¨It´s Time to Walk the Talk¨, released on the […] Continue reading -> Cancer Organizations Across Latin America Vow To Intensify Action Against Expected “Tsunami” Of New Cancer Deaths 05/12/2019 Editorial team For the first time ever, leading cancer organizations across Latin America have signed onto a joint declaration pledging to intensify action against millions of avoidable cancer deaths on the continent. The Bogota Statement on Leading BOLD Cancer Prevention into the Future was signed by leaders of cancer organizations and foundations from 8 Latin American countries, […] Continue reading -> Norway Launches First-Ever Strategy By Major International Donor To Combat Non-Communicable Diseases 22/11/2019 Elaine Ruth Fletcher Oslo – Norway has launched a milestone “Better Health, Better Life” strategy to combat deadly non-communicable (NCDs) diseases as part of its international development assistance. This makes Norway the first to develop a strategy for combating this large and growing global health threat, which currently receives only about 1% of international health assistance. NCDs are […] Continue reading -> Cities Can Reduce NCDs And Traffic Injuries Through Better Environmental Design & Food/Tobacco Policies 31/10/2019 Grace Ren Non-communicable diseases (NCDs) such as cancer, heart disease and stroke, as well as road traffic injuries, are among the leading causes of death in cities – killing some 42 million people worldwide every year. A new report released by the World Health Organization shows how urban leaders can tackle these urban maladies through simple environmental […] Continue reading -> Tobacco Industry Influence in Policy Highest In Japan, Lowest In The UK 11/10/2019 Grace Ren The tobacco industry strongly influences policy-making in Japan, Jordan, Egypt and Bangladesh. Conversely, the United Kingdom, Uganda, and Iran emerge as countries with the least industry meddling, according to a first-ever report to systematically assess levels of industry influence in countries, by the watchdog group STOP (Stopping Tobacco Organizations and Products). “This report shows that […] Continue reading -> Building the Back End of Health Care Finance & Access 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Novartis Relinquishes European Patent For Kymriah Cancer Cell Therapy 17/12/2019 Editorial team Novartis has relinquished a patent granted by the European Patent Office for Kymriah, a promising new gene therapy for certain forms of leukemia, claiming the patent was no longer essential to the development and marketing of the treatment. The decision followed the moves by the Swiss-based NGO, Public Eye and the French-based Doctors of the […] Continue reading -> Leveraging Urban Leaders To Battle NCDs – Healthy Cities Partnership Expands To 70 12/12/2019 Elaine Ruth Fletcher From clearing the air of hookah smoke in Amman, Jordan to bike lanes in Fortaleza, Brazil and salt-free menu options in the restaurants of Montevideo, Uruguay, the Partnership for Healthy Cities has been seeding small grants to cities across the globe – backed by a big ambition. The aim is to build a network of […] Continue reading -> Beat NCDs With Healthier Behaviours, Environments & Education, Says WHO High-Level Commission 10/12/2019 Elaine Ruth Fletcher Make the ¨healthiest choices the easiest choices¨ to prevent many non-communicable diseases. This was a key message from an Independent High-Level Commission report on Non-communicable diseases (NCDs), released Tuesday at a WHO Global Meeting to Accelerate Progress NCDs and Mental Health in Muscat, Oman. The report, ¨It´s Time to Walk the Talk¨, released on the […] Continue reading -> Cancer Organizations Across Latin America Vow To Intensify Action Against Expected “Tsunami” Of New Cancer Deaths 05/12/2019 Editorial team For the first time ever, leading cancer organizations across Latin America have signed onto a joint declaration pledging to intensify action against millions of avoidable cancer deaths on the continent. The Bogota Statement on Leading BOLD Cancer Prevention into the Future was signed by leaders of cancer organizations and foundations from 8 Latin American countries, […] Continue reading -> Norway Launches First-Ever Strategy By Major International Donor To Combat Non-Communicable Diseases 22/11/2019 Elaine Ruth Fletcher Oslo – Norway has launched a milestone “Better Health, Better Life” strategy to combat deadly non-communicable (NCDs) diseases as part of its international development assistance. This makes Norway the first to develop a strategy for combating this large and growing global health threat, which currently receives only about 1% of international health assistance. NCDs are […] Continue reading -> Cities Can Reduce NCDs And Traffic Injuries Through Better Environmental Design & Food/Tobacco Policies 31/10/2019 Grace Ren Non-communicable diseases (NCDs) such as cancer, heart disease and stroke, as well as road traffic injuries, are among the leading causes of death in cities – killing some 42 million people worldwide every year. A new report released by the World Health Organization shows how urban leaders can tackle these urban maladies through simple environmental […] Continue reading -> Tobacco Industry Influence in Policy Highest In Japan, Lowest In The UK 11/10/2019 Grace Ren The tobacco industry strongly influences policy-making in Japan, Jordan, Egypt and Bangladesh. Conversely, the United Kingdom, Uganda, and Iran emerge as countries with the least industry meddling, according to a first-ever report to systematically assess levels of industry influence in countries, by the watchdog group STOP (Stopping Tobacco Organizations and Products). “This report shows that […] Continue reading -> Building the Back End of Health Care Finance & Access 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Leveraging Urban Leaders To Battle NCDs – Healthy Cities Partnership Expands To 70 12/12/2019 Elaine Ruth Fletcher From clearing the air of hookah smoke in Amman, Jordan to bike lanes in Fortaleza, Brazil and salt-free menu options in the restaurants of Montevideo, Uruguay, the Partnership for Healthy Cities has been seeding small grants to cities across the globe – backed by a big ambition. The aim is to build a network of […] Continue reading -> Beat NCDs With Healthier Behaviours, Environments & Education, Says WHO High-Level Commission 10/12/2019 Elaine Ruth Fletcher Make the ¨healthiest choices the easiest choices¨ to prevent many non-communicable diseases. This was a key message from an Independent High-Level Commission report on Non-communicable diseases (NCDs), released Tuesday at a WHO Global Meeting to Accelerate Progress NCDs and Mental Health in Muscat, Oman. The report, ¨It´s Time to Walk the Talk¨, released on the […] Continue reading -> Cancer Organizations Across Latin America Vow To Intensify Action Against Expected “Tsunami” Of New Cancer Deaths 05/12/2019 Editorial team For the first time ever, leading cancer organizations across Latin America have signed onto a joint declaration pledging to intensify action against millions of avoidable cancer deaths on the continent. The Bogota Statement on Leading BOLD Cancer Prevention into the Future was signed by leaders of cancer organizations and foundations from 8 Latin American countries, […] Continue reading -> Norway Launches First-Ever Strategy By Major International Donor To Combat Non-Communicable Diseases 22/11/2019 Elaine Ruth Fletcher Oslo – Norway has launched a milestone “Better Health, Better Life” strategy to combat deadly non-communicable (NCDs) diseases as part of its international development assistance. This makes Norway the first to develop a strategy for combating this large and growing global health threat, which currently receives only about 1% of international health assistance. NCDs are […] Continue reading -> Cities Can Reduce NCDs And Traffic Injuries Through Better Environmental Design & Food/Tobacco Policies 31/10/2019 Grace Ren Non-communicable diseases (NCDs) such as cancer, heart disease and stroke, as well as road traffic injuries, are among the leading causes of death in cities – killing some 42 million people worldwide every year. A new report released by the World Health Organization shows how urban leaders can tackle these urban maladies through simple environmental […] Continue reading -> Tobacco Industry Influence in Policy Highest In Japan, Lowest In The UK 11/10/2019 Grace Ren The tobacco industry strongly influences policy-making in Japan, Jordan, Egypt and Bangladesh. Conversely, the United Kingdom, Uganda, and Iran emerge as countries with the least industry meddling, according to a first-ever report to systematically assess levels of industry influence in countries, by the watchdog group STOP (Stopping Tobacco Organizations and Products). “This report shows that […] Continue reading -> Building the Back End of Health Care Finance & Access 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Beat NCDs With Healthier Behaviours, Environments & Education, Says WHO High-Level Commission 10/12/2019 Elaine Ruth Fletcher Make the ¨healthiest choices the easiest choices¨ to prevent many non-communicable diseases. This was a key message from an Independent High-Level Commission report on Non-communicable diseases (NCDs), released Tuesday at a WHO Global Meeting to Accelerate Progress NCDs and Mental Health in Muscat, Oman. The report, ¨It´s Time to Walk the Talk¨, released on the […] Continue reading -> Cancer Organizations Across Latin America Vow To Intensify Action Against Expected “Tsunami” Of New Cancer Deaths 05/12/2019 Editorial team For the first time ever, leading cancer organizations across Latin America have signed onto a joint declaration pledging to intensify action against millions of avoidable cancer deaths on the continent. The Bogota Statement on Leading BOLD Cancer Prevention into the Future was signed by leaders of cancer organizations and foundations from 8 Latin American countries, […] Continue reading -> Norway Launches First-Ever Strategy By Major International Donor To Combat Non-Communicable Diseases 22/11/2019 Elaine Ruth Fletcher Oslo – Norway has launched a milestone “Better Health, Better Life” strategy to combat deadly non-communicable (NCDs) diseases as part of its international development assistance. This makes Norway the first to develop a strategy for combating this large and growing global health threat, which currently receives only about 1% of international health assistance. NCDs are […] Continue reading -> Cities Can Reduce NCDs And Traffic Injuries Through Better Environmental Design & Food/Tobacco Policies 31/10/2019 Grace Ren Non-communicable diseases (NCDs) such as cancer, heart disease and stroke, as well as road traffic injuries, are among the leading causes of death in cities – killing some 42 million people worldwide every year. A new report released by the World Health Organization shows how urban leaders can tackle these urban maladies through simple environmental […] Continue reading -> Tobacco Industry Influence in Policy Highest In Japan, Lowest In The UK 11/10/2019 Grace Ren The tobacco industry strongly influences policy-making in Japan, Jordan, Egypt and Bangladesh. Conversely, the United Kingdom, Uganda, and Iran emerge as countries with the least industry meddling, according to a first-ever report to systematically assess levels of industry influence in countries, by the watchdog group STOP (Stopping Tobacco Organizations and Products). “This report shows that […] Continue reading -> Building the Back End of Health Care Finance & Access 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Cancer Organizations Across Latin America Vow To Intensify Action Against Expected “Tsunami” Of New Cancer Deaths 05/12/2019 Editorial team For the first time ever, leading cancer organizations across Latin America have signed onto a joint declaration pledging to intensify action against millions of avoidable cancer deaths on the continent. The Bogota Statement on Leading BOLD Cancer Prevention into the Future was signed by leaders of cancer organizations and foundations from 8 Latin American countries, […] Continue reading -> Norway Launches First-Ever Strategy By Major International Donor To Combat Non-Communicable Diseases 22/11/2019 Elaine Ruth Fletcher Oslo – Norway has launched a milestone “Better Health, Better Life” strategy to combat deadly non-communicable (NCDs) diseases as part of its international development assistance. This makes Norway the first to develop a strategy for combating this large and growing global health threat, which currently receives only about 1% of international health assistance. NCDs are […] Continue reading -> Cities Can Reduce NCDs And Traffic Injuries Through Better Environmental Design & Food/Tobacco Policies 31/10/2019 Grace Ren Non-communicable diseases (NCDs) such as cancer, heart disease and stroke, as well as road traffic injuries, are among the leading causes of death in cities – killing some 42 million people worldwide every year. A new report released by the World Health Organization shows how urban leaders can tackle these urban maladies through simple environmental […] Continue reading -> Tobacco Industry Influence in Policy Highest In Japan, Lowest In The UK 11/10/2019 Grace Ren The tobacco industry strongly influences policy-making in Japan, Jordan, Egypt and Bangladesh. Conversely, the United Kingdom, Uganda, and Iran emerge as countries with the least industry meddling, according to a first-ever report to systematically assess levels of industry influence in countries, by the watchdog group STOP (Stopping Tobacco Organizations and Products). “This report shows that […] Continue reading -> Building the Back End of Health Care Finance & Access 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Norway Launches First-Ever Strategy By Major International Donor To Combat Non-Communicable Diseases 22/11/2019 Elaine Ruth Fletcher Oslo – Norway has launched a milestone “Better Health, Better Life” strategy to combat deadly non-communicable (NCDs) diseases as part of its international development assistance. This makes Norway the first to develop a strategy for combating this large and growing global health threat, which currently receives only about 1% of international health assistance. NCDs are […] Continue reading -> Cities Can Reduce NCDs And Traffic Injuries Through Better Environmental Design & Food/Tobacco Policies 31/10/2019 Grace Ren Non-communicable diseases (NCDs) such as cancer, heart disease and stroke, as well as road traffic injuries, are among the leading causes of death in cities – killing some 42 million people worldwide every year. A new report released by the World Health Organization shows how urban leaders can tackle these urban maladies through simple environmental […] Continue reading -> Tobacco Industry Influence in Policy Highest In Japan, Lowest In The UK 11/10/2019 Grace Ren The tobacco industry strongly influences policy-making in Japan, Jordan, Egypt and Bangladesh. Conversely, the United Kingdom, Uganda, and Iran emerge as countries with the least industry meddling, according to a first-ever report to systematically assess levels of industry influence in countries, by the watchdog group STOP (Stopping Tobacco Organizations and Products). “This report shows that […] Continue reading -> Building the Back End of Health Care Finance & Access 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Cities Can Reduce NCDs And Traffic Injuries Through Better Environmental Design & Food/Tobacco Policies 31/10/2019 Grace Ren Non-communicable diseases (NCDs) such as cancer, heart disease and stroke, as well as road traffic injuries, are among the leading causes of death in cities – killing some 42 million people worldwide every year. A new report released by the World Health Organization shows how urban leaders can tackle these urban maladies through simple environmental […] Continue reading -> Tobacco Industry Influence in Policy Highest In Japan, Lowest In The UK 11/10/2019 Grace Ren The tobacco industry strongly influences policy-making in Japan, Jordan, Egypt and Bangladesh. Conversely, the United Kingdom, Uganda, and Iran emerge as countries with the least industry meddling, according to a first-ever report to systematically assess levels of industry influence in countries, by the watchdog group STOP (Stopping Tobacco Organizations and Products). “This report shows that […] Continue reading -> Building the Back End of Health Care Finance & Access 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Tobacco Industry Influence in Policy Highest In Japan, Lowest In The UK 11/10/2019 Grace Ren The tobacco industry strongly influences policy-making in Japan, Jordan, Egypt and Bangladesh. Conversely, the United Kingdom, Uganda, and Iran emerge as countries with the least industry meddling, according to a first-ever report to systematically assess levels of industry influence in countries, by the watchdog group STOP (Stopping Tobacco Organizations and Products). “This report shows that […] Continue reading -> Building the Back End of Health Care Finance & Access 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Building the Back End of Health Care Finance & Access 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> Posts navigation Older postsNewer posts